The global pharmaceutical lactose market size is set to be valued at USD 392.3 million by 2033, recording a CAGR of 5.8% throughout the forecast period (2023 to 2033). Overall pharmaceutical lactose sales are likely to total a valuation of USD 222.6 million in 2023.
Widening applications of pharmaceutical lactose across pharmaceutical sector for making a variety of drugs is expected to help the market thrive during the forecast period.
Over the years, pharmaceutical lactose has become a widely used excipient in pharmaceutical industry due to its excellent physical and functional properties. It is being extensively used as a bulking and filling agent in both capsule and tablet formulations as it fulfills most of the ideal characteristics of bulking agents. It also possesses excellent compressibility properties.
Rising consumption of pharmaceutical formulations such as tablets and capsules is expected to boost the global pharmaceutical lactose industry during the projection period.
Similarly, development of new medicines for chronic diseases, increased investment in research & development, and the introduction of new technologies will create lucrative growth for pharmaceutical lactose manufacturers.
Pharmaceutical lactose is in high demand due to its versatility in several applications, including altering drug release, taste masking, and enhancing the stability of active pharmaceutical ingredients. The demand for pharmaceutical lactose has also increased due to the growing use of excipients to increase medication solubility and boost bioavailability.
Innovation in drug delivery is expected to create new growth prospects for pharmaceutical lactose industry over the next ten years. The advent of new treatments will create interest in unique forms of drug delivery. This in turn will help the market thrive rapidly.
| Attribute | Key Insights |
|---|---|
| Pharmaceutical Lactose Market Estimated Value (2023) | USD 222.6 million |
| Projected Market Value (2033) | USD 392.3 million |
| Value-based CAGR (2023 to 2033) | 5.8% |
| Top 3 Countries’ Market Share | 18.2% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
According to Future Market Insights’ analysis, global sales of pharmaceutical witnessed a CAGR of 5.1% between 2018 and 2022. However, for the forecast period of 2023 and 2033, the global pharmaceutical lactose industry is projected to expand at 5.8% CAGR.
Increasing demand for pharmaceutical lactose across booming pharmaceutical industry is a key factor expected to drive the global market swiftly during the assessment period. Growing propensity for preventative healthcare is another factor that will elevate pharmaceutical lactose demand in the global market.
Similarly, increasing investments by domestic and international businesses in pharmaceutical sector, particularly in emerging markets such as China and Brazil, is expected to positively affect the development of the pharmaceutical lactose over the projection period.
Rising awareness about the functions and health benefits associated with pharmaceutical lactose has led to the influx of new players who are focusing on launching innovative products as well as focusing on partnerships to increase production capacity.
Lactose for inhalation is an excipient with high functionality that aids in the reliable performance of dry powder inhalation and subsequently benefits the patient's health. Key players, end users, suppliers, and regulators are working deeply to understand the inhalation lactose benefits.
Inhalation lactose continues to be appealing in the worldwide pharmaceutical lactose market due to its significance in DPI performance, which has drawn considerable regulatory scrutiny.
The aim of improving palatability in oral drugs has driven the growth of various formulations with improved acceptability and performance. Pharmaceuticals such as mouth-dissolving tablets have gained wide popularity.
These mouth-dissolving tablets are generally prepared by using numerous conventional methods, such as wet granulation, molding, direct compression, spray drying, sublimation and freeze drying, etc. Rising usage of pharmaceutical lactose for manufacturing solid dosage forms such as tablets and capsules and subsequent consumption of these products will foster sales.
Usage of 3D Models to Enhance Precision in Pharmaceutical Lactose to Boost Market
With the introduction of 3D printing technology, it is now possible to design and produce unique, intricate drug items in the pharmaceutical business. The capacity to customize doses for particular users is provided by 3D printing, which enables the development of trustworthy dosage forms for clinical usage.
Pharmaceutical lactose producers are employing 3D technology to create lactose blends with enough flow, wetting, and binding to take advantage of new prospects. The pharmaceutical business is increasingly using 3D printing due to advantages including early-phase drug research, great dose flexibility, and enabling personalized therapy.
About 1% of the drugs that are investigated make it through testing and gain approval. However, new technology is being pursued which accommodates increased precision in drug discovery.
The benefit of 3D models is that they allow for greater predictability of a drug's toxicity and effectiveness before it enters the clinical trial phase, which can improve the attrition rate of new pharmaceuticals and also hasten the process of discovering new drugs.
Principal Consultant
Increasing consumption of Pharmaceutical Capsules and Tablets Boosting Market in Mexico
According to Future Market Insights, Mexico is expected to hold about 5.8% share of the global pharmaceutical lactose industry by 2033, making it one of the most lucrative markets across Latin America. Rising demand for solid dosage forms such as tablets and capsules is a key factor driving market for pharmaceutical lactose across Mexico.
Mexico is a rapidly growing hub for medical technology in Latin America. It has been attracting foreign investments during the last few years due to favorable government support. Increased penetration of leading pharmaceutical companies and the adoption of new oral drug technologies in Mexico are anticipated to boost pharmaceutical lactose sales in the country.
Similarly, growing health awareness and adoption of advanced drug delivery technologies will elevate pharmaceutical lactase demand across Mexico during the next ten years.
Large Presence of Pharmaceutical Companies Making the USA a Lucrative Market for Pharmaceutical lactose
The United States is currently dominating North America pharmaceutical lactose market with a market share of around 78.2% and it is likely to retain its dominance during the forecast period.
Rising healthcare spending, development of novel medicines, and presence of a well-established pharmaceutical industry are few of the leading factors driving the USA pharmaceutical lactose market.
Similarly, ongoing medical research and clinical trials, rising prevalence of chronic diseases, and technological advancements in customized biologicals and advanced drugs are expected to positively impact pharmaceutical lactose demand in the country.
The United States is home to several leading pharmaceutical giants that are constantly investing in research and development activities to discover novel treatments. Thanks to heavy presence of these players, the country is witnessing high demand for excipients such as lactose and the trend is expected to continue during the next ten years.
Α-Lactose Monohydrate Remains the Top-Selling Product Category
Based on product type, the global market for pharmaceutical lactose is segmented into α-lactose monohydrate, β-lactose -lactose, amorphous lactose, and Spray dried lactose.
Among these, α-lactose monohydrate segment dominates the global pharmaceutical lactose industry and it is expected to accelerate at a significant pace over the next ten years. This is attributed to rising usage of α-lactose monohydrate as a filler and dilute in various pharmaceutical formulations.
In the pharmaceutical industry, A-lactose monohydrate is widely used as an excipient in the production of solid dosage forms. Similarly, in dry powder inhalers, it is used as a carrier.
The pharmaceutical products in which α-lactose monohydrate is used as a primary ingredient have a higher shelf life as compared to other products in which the rest of the pharmaceutical lactose types are used.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The global market for pharmaceutical lactose is witnessing a rise in competition as more and more market players belonging to the lactose industry are taking an interest in venturing into this B2B business model.
Due to rising competition in the market, key pharmaceutical lactose manufacturers are launching innovative products to strengthen their position in the global market. They are utilizing strategies such as partnerships, joint ventures, acquisitions, facility expansions, and collaborations to expand their geographical reach.
Few of the leading pharmaceutical lactose companies include Ba’emek Advanced Technologies, Armor Pharma, Hilmar Ingredients, Avantor, Inc., Lactose (India) Limited, Kerry plc, Milei GmbH, Alpavit Käserei Champignon Hofmeister GmbH & Co. KG, BASF SE, DFE Pharma, Hoogwegt Groep B.V., MEGGLE Excipients & Technology, and Merck KgaA.
Recent Developments:
| Attribute | Details |
|---|---|
| Estimated Market Size (2023) | USD 222.6 million |
| Projected Market Size (2033) | USD 392.3 million |
| Anticipated Growth Rate (2023 to 2033) | 5.8% CAGR |
| Forecast Period | 2023 to 2033 |
| Historical Data Available for | 2018 to 2022 |
| Market Analysis | USD million for value and Metric Tons for Volume |
| Key Regions Covered | North America; Latin America; Europe; East Asia; South Asia; Oceania; and the Middle East & Africa |
| Key Countries Covered | United States, Canada, Brazil, Mexico, Chile, Peru, Argentina, Rest of Latin America, Germany, France, Italy, United Kingdom, Spain, BENELUX, Nordic, Poland, Russia, Rest of Europe, China, Japan, South Korea, India, Malaysia, Singapore, Indonesia, Thailand, Rest of South Asia, Australia, New Zealand, GCC Countries, South Africa, Türkiye, North Africa, Central Africa, Rest of Middle East & Africa |
| Key Segments Covered | Product Type and Region |
| Key Companies Profiled | Ba'emek Advanced Technologies Ltd (Tnuva Group); Hilmar Ingredients; Armor Pharma; Avantor, Inc.; Alpavit Käserei Champignon Hofmeister GmbH & Co. KG; Lactose (India) Limited; DFE Pharma; Hoogwegt Groep B.V.; Merck KgaA; Kerry plc; Milei GmbH; BASF SE; MEGGLE Excipients & Technology |
| Report Coverage | Market Forecast, brand share analysis, competition intelligence, DROT analysis, Market Dynamics and Challenges, Strategic Growth Initiatives |
A valuation of USD 222.6 million is attributed to the pharmaceutical lactose market in 2023.
The global market size is anticipated to surpass USD 392.3 million by 2033.
The market is projected to accelerate at a CAGR of 5.8% between 2023 and 2033.
Growing demand for lactose-based products makes the United States a lucrative pharmaceutical lactose market.
The pharmaceutical lactose market experienced a steady 5.1% CAGR from 2018 to 2022.
1. Executive Summary | Pharmaceutical Lactose Market 2. Market Overview 3. Market Background 4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033 5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product Type 5.1. Β-Lactose 5.2. α-Lactose monohydrate 5.3. Amorphous Lactose 5.4. Spray Dried Lactose 6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region 6.1. North America 6.2. Latin America 6.3. Europe 6.4. East Asia 6.5. South Asia 6.6. Oceania 6.7. Middle East & Africa 7. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 8. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 9. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 10. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 11. South Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 12. Oceania Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 13. Middle East & Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 14. Key Countries Market Analysis 15. Market Structure Analysis 16. Competition Analysis 16.1. Ba'emek Advanced Technologies Ltd (Tnuva Group) 16.2. Hilmar Ingredients 16.3. Armor Pharma 16.4. Avantor, Inc. 16.5. Alpavit Käserei Champignon Hofmeister GmbH & Co. KG 16.6. Lactose (India) Limited 16.7. DFE Pharma 16.8. Hoogwegt Groep B.V. 16.9. Merck KgaA 16.10. Kerry plc 16.11. Miles GmbH 16.12. BASF SE 16.13. MEGGLE Excipients & Technology 17. Assumptions & Acronyms Used 18. Research Methodology
Explore Food and Beverage Insights
View Reports
Pharmaceutical Lactose Market
